Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9249 - 9256 of 12089 results
SEC Finalizes the CEO Pay Ratio Rule - Additional Executive Compensation Disclosure for Public Companies Beginning in 2017
August 7, 2015| Blog| Viewpoint
More Paid Sick Leave on the Horizon? Draft Executive Order Calls for Paid Sick Leave for Federal Contractors and Subcontractors.
August 6, 2015| Blog| Viewpoint
Big Week for Energy Policy Ahead of August Recess
August 6, 2015| Blog| Viewpoint
EB-5 Processing Times: Continued Delays with I-526, I-829 and I-924 Adjudications
August 6, 2015| Blog| Viewpoint
Drug Pumps Are Vulnerable to Hacking, FDA Warns
August 6, 2015| Blog| Viewpoint
ML Strategies: CMS Releases Final Payment Rules and Lawmakers target CMS’ Mandatory Home Health Value-Based Purchasing Pilot
August 6, 2015| Blog| Viewpoint
EU Data Protection Regulation – Did you know there’s an app for that?
August 6, 2015| Blog| Viewpoint
EB-5 Processing Times: Continued Delays
August 6, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|